Protokinetix Stock Today

PKTX Stock  USD 0.01  0.0008  9.88%   

Performance

1 of 100

 
Weak
 
Strong
Weak

Odds Of Distress

Less than 42

 
High
 
Low
Below Average
Protokinetix is trading at 0.0089 as of the 2nd of December 2024; that is 9.88 percent increase since the beginning of the trading day. The stock's open price was 0.0081. Protokinetix has about a 42 percent probability of financial distress in the next few years of operation and did not have a very good performance during the last 90 trading days. Equity ratings for Protokinetix are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of October 2024 and ending today, the 2nd of December 2024. Click here to learn more.
ProtoKinetix, Incorporated, a research and development stage bio-technology company, focuses on the scientific medical research of anti-freeze glycoproteins or anti-aging glycoproteins . ProtoKinetix, Incorporated was incorporated in 1999 and is based in Marietta, Ohio. The company has 316.85 M outstanding shares. More on Protokinetix

Moving together with Protokinetix Pink Sheet

  0.71NVO Novo Nordisk ASPairCorr
  0.68NONOF Novo Nordisk ASPairCorr
  0.66REGN Regeneron PharmaceuticalsPairCorr

Moving against Protokinetix Pink Sheet

  0.68JXN-PA Jackson FinancialPairCorr
  0.64CAT Caterpillar Fiscal Year End 3rd of February 2025 PairCorr
  0.59BMYMP Bristol Myers SquibbPairCorr
  0.59MET MetLife Sell-off TrendPairCorr
  0.57NVDA NVIDIAPairCorr
  0.53META Meta Platforms Aggressive PushPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Protokinetix Pink Sheet Highlights

Chairman, CEO and PresClarence Smith
Business ConcentrationBiotechnology, Healthcare (View all Sectors)
Protokinetix [PKTX] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.51 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Protokinetix's market, we take the total number of its shares issued and multiply it by Protokinetix's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Protokinetix conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 316.85 M outstanding shares. Protokinetix currently holds about 18.83 K in cash with (889.89 K) of positive cash flow from operations.
Check Protokinetix Probability Of Bankruptcy
Ownership Allocation
Protokinetix owns a total of 316.85 Million outstanding shares. Protokinetix has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Protokinetix Ownership Details

Protokinetix Risk Profiles

Protokinetix Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Protokinetix without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Instant Ratings Now

   

Instant Ratings

Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
All  Next Launch Module

Additional Tools for Protokinetix Pink Sheet Analysis

When running Protokinetix's price analysis, check to measure Protokinetix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protokinetix is operating at the current time. Most of Protokinetix's value examination focuses on studying past and present price action to predict the probability of Protokinetix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protokinetix's price. Additionally, you may evaluate how the addition of Protokinetix to your portfolios can decrease your overall portfolio volatility.